Lyman S D, Poland A
Biochem Pharmacol. 1983 Nov 15;32(22):3345-50. doi: 10.1016/0006-2952(83)90360-x.
Mice carrying the recessive mutation brachymorphic have been shown previously to have a reduced capacity to synthesize 3'-phosphoadenosine-5'-phosphosulfate (PAPS), the required coenzyme in sulfation reactions [K. Sugahara and N. Schwartz, Proc. natn. Acad. Sci. U.S.A. 76, 6615 (1979)]. The capacity of the liver cytosol fractions from brachymorphic (bm/bm) mice or their phenotypically normal littermates (+/+ or +/bm) to catalyze the formation of sulfate esters of [3H]estrone and [14C]p-nitrophenol in vitro was determined. When PAPS was added to the reaction, the rates of sulfate ester formation catalyzed by the two cytosol fractions were similar. In contrast, when PAPS was generated in situ from ATP and SO(4)2-, the rates of sulfate ester formation catalyzed by the brachymorphic cytosol were only 4-22% of the rates catalyzed by the cytosol fraction from normal mice. The hepatic cytosol fraction from brachymorphic mice incorporated less 35SO(4)2- into PAPS than that catalyzed by cytosol of normal mice. [14C]p-Nitrophenol (1.5 mumoles/kg) was eliminated from brachymorphic and normal mice as urinary conjugates; in normal mice, 73% of the urinary radioactivity was p-nitrophenyl sulfate, while in the brachymorphic mice only 33% of the urinary excretion was the sulfate ester. Brachymorphic mice have a reduced capacity for synthesizing sulfate esters of xenobiotics in vitro and in vivo, which is attributable to their reduced synthesis of PAPS.
先前已表明,携带隐性突变短形的小鼠合成3'-磷酸腺苷-5'-磷酸硫酸酯(PAPS)的能力降低,PAPS是硫酸化反应中所需的辅酶[K. 菅原和N. 施瓦茨,《美国国家科学院院刊》76, 6615 (1979)]。测定了来自短形(bm/bm)小鼠或其表型正常的同窝小鼠(+/+或+/bm)的肝脏胞质溶胶部分在体外催化[3H]雌酮和[14C]对硝基苯酚硫酸酯形成的能力。当向反应中加入PAPS时,两种胞质溶胶部分催化的硫酸酯形成速率相似。相比之下,当从ATP和SO(4)2-原位生成PAPS时,短形胞质溶胶催化的硫酸酯形成速率仅为正常小鼠胞质溶胶部分催化速率的4-22%。短形小鼠的肝脏胞质溶胶部分比正常小鼠的胞质溶胶催化掺入PAPS中的35SO(4)2-更少。[14C]对硝基苯酚(1.5微摩尔/千克)以尿结合物的形式从短形和正常小鼠体内消除;在正常小鼠中,7